Related Experiment Video
Updated: May 28, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Variable selection for qualitative interactions in personalized medicine while controlling the family-wise error rate
Lacey Gunter1, Ji Zhu, Susan Murphy
1Gunter Statistical Consulting, Provo, Utah 84604, USA. laceygunter@gmail.com
Journal of Biopharmaceutical Statistics
|October 26, 2011
Summary
This study introduces a new statistical method to identify patient subsets that respond differently to treatments, advancing personalized medicine. The technique enhances the power of detecting treatment effect variations within specific genomic subsets.
Area of Science:
- Biostatistics
- Clinical Trials
- Genomics
- Personalized Medicine
Background:
- Subset analysis is crucial in biostatistics and clinical trials.
- Identifying genomic subsets that alter treatment effects is key for personalized medicine.
- Current methods for detecting such subsets lack power and are limited.
Purpose of the Study:
- To address the limitations in detecting subsets with differential treatment effects.
- To propose and evaluate a novel variable selection technique for qualitative interactions.
- To discover critical patient subsets influencing treatment outcomes.
Main Methods:
- Developed a new technique for variable selection focused on qualitative interactions.
- Aimed to identify interaction variables within large datasets.
- Controlled for the number of false discoveries during analysis.
Main Results:
- The proposed method was compared against standard qualitative interaction tests.
- Simulations were used to assess the performance of the new technique.
- The method's utility was demonstrated on a depression treatment randomized controlled trial dataset.
Conclusions:
- The new technique shows promise for discovering patient subsets with altered treatment effects.
- This approach can improve the precision of personalized medicine strategies.
- Further application of this method can advance the field of stratified medicine.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...